Sarepta shareholders approve 4.3M share increase to 2018 equity plan, 0.3M to ESPP

Sarepta Therapeutics, Inc.

Vote approves adding 4,300,000 shares to 2018 Equity Incentive Plan (total now 17,487,596).
Vote approves adding 300,000 shares to 2016 ESPP (total now 1,700,000 shares).
Re-elected directors Barry, Behrens, Mayo, Nicaise with majority support.
Advisory vote on 2024 named executive officer compensation passed (72.1M for, 2.2M against).
Ratified KPMG as independent auditor for FY2025 (80.6M for, 3.9M against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.